Prostate cancer
Adverse pathology at radical prostatectomy
Obiettivo della formazione: Aim of this course is to provide insights into the most appropriate treatment of patients presenting with adverse features at RP + ePLND.
Specializzazione: Urology, Radiation oncology, Medical oncology
Pubblico target: CME (basic), Residents (senior)
Aggiornamento più recente: January 2022
Premessa:
Patients who present with adverse pathology at radical prostatectomy (RP) + extended pelvic lymph node extension (ePLND) are at higher risk of recurrence. The most appropriate therapy for these patients differs according to the type and number of adverse features.